U.S. Health Secretary Alex Azar said if pharmaceutical company Pfizer Inc. submits interim Covid-19 vaccine to health regulators as quickly as expected, the U.S. government anticipates the beginning of vaccinating Americans in December.
‘Great day for humanity’: Pfizer says Covid-19 vaccine over 90% effective
Analysis, BioNTech, Business, Clinical Trials, CNBC, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Vaccines, Donald Trump, Efficacy, Health Experts, Joe Biden, Messenger RNA (mRNA) Vaccines, Moderna, Pfizer, R&D, Stock Markets, U.S. governmentPfizer Inc.’s experimental Covid-19 vaccine was more than 90% effective based on initial trial results, the company said, a major victory in the fight against a pandemic that has killed more than 1 million people and battered the world’s economy.